{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:52:19Z","timestamp":1780563139455,"version":"3.54.1"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Tobacco smoking is an established risk factor associated with bladder cancer, yet its impact on bladder cancer prognosis is unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine associations of use of tobacco (cigarettes, pipes, and cigars), e-cigarettes, and marijuana with risk of recurrence and progression of non\u2013muscle-invasive bladder cancer (NMIBC) and to explore use of smoking cessation interventions.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>The Be-Well Study is a prospective cohort study of patients with NMIBC diagnosed from 2015 to 2019 and followed-up for 26.4 months in the Kaiser Permanente Northern and Southern California integrated health care system. Eligibility criteria were age at least 21 years, first NMIBC diagnosis (stages Ta, Tis, or T1), alive, and not in hospice care. Exclusion criteria were previous diagnosis of bladder cancer or other cancer diagnoses within 1 year prior to or concurrent with NMIBC diagnosis. Data were analyzed from April 1 to October 4, 2022.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Use of cigarettes, pipes, cigars, e-cigarettes, and marijuana was reported in the baseline interview. Use of smoking cessation interventions (counseling and medications) was derived from electronic health records.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Hazard ratios (HRs) and 95% CIs of recurrence and progression of bladder cancer were estimated by multivariable Cox proportional hazards regression.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 1472 patients (mean [SD] age at diagnosis, 70.2 [10.8%] years; 1129 [76.7%] male patients) with NMIBC were enrolled at a mean (SD) of 2.3 (1.3) months after diagnosis, including 874 patients (59.4%) who were former smokers and 111 patients (7.5%) who were current cigarette smokers; 67 patients (13.7%) smoked pipes and\/or cigars only, 65 patients (4.4%) used e-cigarettes, 363 patients (24.7%) used marijuana. Longer cigarette smoking duration and more pack-years were associated with higher risk of recurrence in a dose-dependent manner, with the highest risks for patients who had smoked for 40 or more years (HR, 2.36; 95% CI, 1.43-3.91) or 40 or more pack-years (HR, 1.97; 95% CI, 1.32-2.95). There was no association of having ever smoked, being a former or current cigarette smoker, and years since quit smoking with recurrence risk. No associations with pipes, cigars, e-cigarettes, or marijuana were found. Of 102 patients offered a smoking cessation intervention, 57 (53.8%) received an interventions after diagnosis, with female patients more likely than male patients to engage in such interventions (23 of 30 female patients [76.7%] vs 34 of 76 male patients [44.7%];P<\/jats:italic>\u2009=\u2009.003).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings suggest that longer duration and more pack-years of cigarette smoking were associated with higher risk of NMIBC recurrence. Cigarette smoking remains a critical exposure before and after diagnosis in survivors of NMIBC.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.44430","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T16:32:59Z","timestamp":1669825979000},"page":"e2244430","source":"Crossref","is-referenced-by-count":29,"title":["Smoking Behaviors and Prognosis in Patients With Non\u2013Muscle-Invasive Bladder Cancer in the Be-Well Study"],"prefix":"10.1001","volume":"5","author":[{"given":"Marilyn L.","family":"Kwan","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena"},{"name":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C.","family":"Young-Wolff","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janise M.","family":"Roh","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac J.","family":"Ergas","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Cannavale","sequence":"additional","affiliation":[{"name":"Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Ambrosone","sequence":"additional","affiliation":[{"name":"Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald K.","family":"Loo","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaiser Permanente Downey Medical Center, Downey, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Aaronson","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaiser Permanente Oakland Medical Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Quesenberry","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Kushi","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"issue":"7","key":"zoi221254r2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women.","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"zoi221254r3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018.","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"zoi221254r4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q","article-title":"The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies.","volume":"89","author":"Zeegers","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"zoi221254r5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ije\/dyw044","article-title":"Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies.","volume":"45","author":"van Osch","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"10061","key":"zoi221254r6","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer.","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"zoi221254r7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1464-410X.2002.02880.x","article-title":"Does smoking status influence the prognosis of bladder cancer: a systematic review.","volume":"90","author":"Aveyard","year":"2002","journal-title":"BJU Int"},{"issue":"11","key":"zoi221254r8","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6","article-title":"Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder.","volume":"86","author":"Fleshner","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"zoi221254r9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.eururo.2011.07.010","article-title":"Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer.","volume":"60","author":"Lammers","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"zoi221254r10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2012.08.025","article-title":"Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.","volume":"63","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"zoi221254r11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cncr.28394","article-title":"Body mass and smoking are modifiable risk factors for recurrent bladder cancer.","volume":"120","author":"Wyszynski","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"zoi221254r12","doi-asserted-by":"crossref","first-page":"65.e9","DOI":"10.1016\/j.urolonc.2014.06.002","article-title":"The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.","volume":"33","author":"Grotenhuis","year":"2015","journal-title":"Urol Oncol"},{"issue":"12","key":"zoi221254r13","doi-asserted-by":"crossref","first-page":"833.e19","DOI":"10.1016\/j.urolonc.2021.04.028","article-title":"Association of smoking status and recurrence of non\u2013muscle invasive bladder cancer among patients managed with blue light cystoscopy.","volume":"39","author":"Matulewicz","year":"2021","journal-title":"Urol Oncol"},{"issue":"2","key":"zoi221254r14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.urology.2012.09.040","article-title":"Cigarette smoking status at diagnosis and recurrence in intermediate-risk non\u2013muscle-invasive bladder carcinoma.","volume":"81","author":"Serretta","year":"2013","journal-title":"Urology"},{"issue":"3","key":"zoi221254r15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.juro.2012.04.110","article-title":"Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases.","volume":"188","author":"Bjurlin","year":"2012","journal-title":"J Urol"},{"key":"zoi221254r16","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2022.01.012","article-title":"Awareness of smoking as a risk factor in bladder cancer: results from the prospective FinnBladder 9 trial.","author":"Sell","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"5","key":"zoi221254r17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.juro.2010.06.140","article-title":"Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists.","volume":"184","author":"Bjurlin","year":"2010","journal-title":"J Urol"},{"issue":"3","key":"zoi221254r18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/JU.0000000000002360","article-title":"Assessment of tobacco screening and smoking cessation recommendations among bladder cancer guidelines: a call to action.","volume":"207","author":"Michael","year":"2022","journal-title":"J Urol"},{"issue":"2","key":"zoi221254r19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10552-019-1130-8","article-title":"The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.","volume":"30","author":"Kwan","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"4","key":"zoi221254r21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jada.2007.01.016","article-title":"Cruciferous vegetable intake questionnaire improves cruciferous vegetable intake estimates.","volume":"107","author":"Thomson","year":"2007","journal-title":"J Am Diet Assoc"},{"issue":"2","key":"zoi221254r22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4278\/ajhp.140821-QUAN-424","article-title":"Telephone-based coaching.","volume":"31","author":"Boccio","year":"2017","journal-title":"Am J Health Promot"},{"issue":"1","key":"zoi221254r23","first-page":"1049","article-title":"The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration.","volume":"2","author":"Ross","year":"2014","journal-title":"EGEMS (Wash DC)"},{"issue":"4","key":"zoi221254r25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non\u2013muscle invasive bladder cancer: AUA\/SUO guideline.","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"12","key":"zoi221254r26","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1586\/14737140.6.12.1723","article-title":"Superficial bladder cancer: part 1\u2014update on etiology, classification and natural history.","volume":"6","author":"Josephson","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"zoi221254r27","doi-asserted-by":"crossref","first-page":"v106","DOI":"10.1093\/annonc\/mdj963","article-title":"Challenges in the treatment of bladder cancer.","volume":"17","author":"Kaufman","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"zoi221254r28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"issue":"1","key":"zoi221254r29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model.","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"issue":"2","key":"zoi221254r30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1464-410X.2007.06873.x","article-title":"Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer.","volume":"100","author":"Chen","year":"2007","journal-title":"BJU Int"},{"issue":"5-6","key":"zoi221254r31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000507122","article-title":"Does smoking cessation at primary diagnosis reduce the recurrence risk of nonmuscle-invasive bladder cancer: results of a prospective study.","volume":"104","author":"Serretta","year":"2020","journal-title":"Urol Int"},{"issue":"7","key":"zoi221254r32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10552-018-1046-8","article-title":"The association between smoking cessation before and after diagnosis and non\u2013muscle-invasive bladder cancer recurrence: a prospective cohort study.","volume":"29","author":"van Osch","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"6","key":"zoi221254r33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/JU.0000000000002449","article-title":"Association of biochemically verified post-diagnosis smoking and non\u2013muscle invasive bladder cancer recurrence risk.","volume":"207","author":"Furberg","year":"2022","journal-title":"J Urol"},{"issue":"5","key":"zoi221254r34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1158\/1940-6207.CAPR-18-0441","article-title":"Smoking cessation and the risk of bladder cancer among postmenopausal women.","volume":"12","author":"Li","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"zoi221254r35","doi-asserted-by":"crossref","first-page":"25.e21","DOI":"10.1016\/j.urolonc.2012.09.001","article-title":"Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study.","volume":"32","author":"Welty","year":"2014","journal-title":"Urol Oncol"},{"issue":"15","key":"zoi221254r36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1200\/JCO.2011.36.6518","article-title":"Impact of a bladder cancer diagnosis on smoking behavior.","volume":"30","author":"Bassett","year":"2012","journal-title":"J Clin Oncol"},{"key":"zoi221254r37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.urology.2020.12.033","article-title":"Prevalence and correlates of successful smoking cessation in bladder cancer survivors.","volume":"153","author":"Bassett","year":"2021","journal-title":"Urology"},{"issue":"5","key":"zoi221254r38","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.juro.2012.11.075","article-title":"Brief smoking cessation intervention: a prospective trial in the urology setting.","volume":"189","author":"Bjurlin","year":"2013","journal-title":"J Urol"},{"key":"zoi221254r39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jss.2018.12.022","article-title":"Evaluation of a pilot perioperative smoking cessation program: a pre-post study.","volume":"237","author":"Young-Wolff","year":"2019","journal-title":"J Surg Res"},{"issue":"3","key":"zoi221254r40","first-page":"452","article-title":"Implementing a multifaceted perioperative smoking cessation intervention in a large healthcare system.","volume":"22","author":"Young-Wolff","year":"2020","journal-title":"Nicotine Tob Res"},{"key":"zoi221254r24","volume-title":"Annual Report: March 2022","author":"Kaiser Permanente Southern California Cancer Registry","year":"2020"},{"key":"zoi221254r1","unstructured":"American Cancer Society. Cancer facts & figures 2022. Accessed October 24, 2022. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2022.html"},{"key":"zoi221254r20","unstructured":"NutritionQuest. Accessed January 15, 2022. https:\/\/www.nutritionquest.com\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799072\/kwan_2022_oi_221254_1669128838.28739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:12:18Z","timestamp":1728501138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44430","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]}}}